Evolutionary Diversity as a Source for Anticancer Molecules

Akhileshwar Kumar Srivastava, Vinod Kumar Kannaujiya, Rajesh Kumar Singh, Divya Singh

Research output: Book/ReportBookpeer-review

2 Scopus citations

Abstract

Evolutionary Diversity as a Source for Anticancer Molecules discusses evolutionary diversity as source for anticancer agents derived from bacteria, algae, bryophytes, pteridophytes, and gymnosperms. The book goes over the isolation of anticancer agents and the technologyenabled screening process used to develop anticancer drugs. The book also includes discussion of the nutraceuticals and natural products derived from invertebrates that can be used as part of cancer treatment. Evolutionary Diversity as a Source for Anticancer Molecules also deals with some of the current challenges in the prevention of cancer as well as the side effects of conventional drugs used for cancer patients. This book is a valuable resource for cancer researchers, oncologists, biotechnologists, pharmacologists, and any member of the biomedical field interested in understanding more about natural products with anticancer potential.

Original languageEnglish
PublisherElsevier Science Ltd.
Number of pages369
ISBN (Electronic)9780128217108
ISBN (Print)9780128216989
DOIs
StatePublished - 1 Jan 2020
Externally publishedYes

ASJC Scopus subject areas

  • General Agricultural and Biological Sciences
  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Evolutionary Diversity as a Source for Anticancer Molecules'. Together they form a unique fingerprint.

Cite this